Supporting the biological function and clinical effect of LGR5 rs17109924 T>C, Kleist et al.35 found a significantly lower immunohistochemical LGR5 expression and a longer TTR in patients with LGR5 variant alleles compared with LGR5 wild-type in stage III CRC. This evidence concerns the gene TTR and colorectal carcinoma.